How fullerene derivatives (FDs) act on therapeutically important targets associated with diabetic diseases.

Anti-diabetic targets Fullerene derivatives Fullerene-based nanoparticles Neural network models Protein–ligand binding

Journal

Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369

Informations de publication

Date de publication:
2022
Historique:
received: 09 11 2021
revised: 09 02 2022
accepted: 09 02 2022
entrez: 4 3 2022
pubmed: 5 3 2022
medline: 5 3 2022
Statut: epublish

Résumé

Fullerene derivatives (FDs) belong to a relatively new family of nano-sized organic compounds. They are widely applied in materials science, pharmaceutical industry, and (bio) medicine. This research focused on the study of FDs in terms of their potential inhibitory effect on therapeutic targets associated with diabetic disease, as well as analysis of protein-ligand binding in order to identify the key binding characteristics of FDs. Therapeutic drug compounds when entering the biological system usually inevitably encounter and interact with a vast variety of biomolecules that are responsible for many different functions in organisms. Protein biomolecules are the most important functional components and used in this study as target structures. The structures of proteins [(PDB ID: 1BMQ, 1FM6, 1GPB, 1H5U, 1US0)] belonging to the class of anti-diabetes targets were obtained from the Protein Data Bank (PDB). Protein binding activity data (binding scores) were calculated for the dataset of 169 FDs related to these five proteins. Subsequently, the resulting data were analyzed using various machine learning and cheminformatics methods, including artificial neural network algorithms for variable selection and property prediction. The Quantitative Structure-Activity Relationship (QSAR) models for prediction of binding scores activity were built up according to five Organization for Economic Co-operation and Development (OECD) principles. All the data obtained can provide important information for further potential use of FDs with different functional groups as promising medical antidiabetic agents. Binding scores activity can be used for ranking of FDs in terms of their inhibitory activity (pharmacological properties) and potential toxicity.

Identifiants

pubmed: 35242284
doi: 10.1016/j.csbj.2022.02.006
pii: S2001-0370(22)00043-5
pmc: PMC8861571
doi:

Types de publication

Journal Article

Langues

eng

Pagination

913-924

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

ACS Med Chem Lett. 2013 Oct 23;4(12):1169-72
pubmed: 24900624
Nanomaterials (Basel). 2020 Jan 02;10(1):
pubmed: 31906497
J Comput Aided Mol Des. 2000 Mar;14(3):251-64
pubmed: 10756480
Diabetes Care. 1992 Mar;15(3):318-68
pubmed: 1532777
Int J Nanomedicine. 2007;2(4):639-49
pubmed: 18203430
Chem Rev. 2013 Jul 10;113(7):5262-321
pubmed: 23570603
J Mater Chem B. 2017;5(32):6523-6535
pubmed: 29225883
J Chem Inf Model. 2015 Feb 23;55(2):460-73
pubmed: 25558886
Basic Clin Pharmacol Toxicol. 2011 Nov;109(5):381-6
pubmed: 21668649
Drugs. 2004;64(12):1339-58
pubmed: 15200348
Bioorg Med Chem Lett. 2005 Aug 1;15(15):3615-8
pubmed: 15978810
Nature. 2001 Dec 13;414(6865):782-7
pubmed: 11742409
Biochem Pharmacol. 2012 Jun 15;83(12):1674-81
pubmed: 22414727
J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):485-92
pubmed: 12653512
J Exp Pharmacol. 2020 Jan 10;12:1-15
pubmed: 32021494
J Ethnopharmacol. 2013 Jul 9;148(2):492-7
pubmed: 23665164
Drug Discov Today. 2008 Apr;13(7-8):285-94
pubmed: 18405840
Nat Chem Biol. 2008 Nov;4(11):682-90
pubmed: 18936753
Nucleic Acids Res. 2019 Jan 8;47(D1):D464-D474
pubmed: 30357411
J Chem Inf Model. 2016 Oct 24;56(10):2024-2034
pubmed: 27649447
Environ Sci Pollut Res Int. 2015 Jun;22(11):8264-71
pubmed: 25520208
Bioorg Med Chem Lett. 2005 Feb 15;15(4):1107-9
pubmed: 15686922
Curr Opin Chem Biol. 2006 Aug;10(4):357-61
pubmed: 16814592
Eur J Med Chem. 2008 Apr;43(4):714-40
pubmed: 17629592
ACS Appl Mater Interfaces. 2016 Oct 5;8(39):25770-25776
pubmed: 27610478
Nanoscale. 2017 Jul 27;9(29):10263-10276
pubmed: 28696446
Nat Biotechnol. 2006 Jul;24(7):805-15
pubmed: 16841068
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
ACS Med Chem Lett. 2012 Jan 17;3(2):155-8
pubmed: 24900445
Dokl Biochem Biophys. 2019 Sep;488(1):320-323
pubmed: 31768851
Org Biomol Chem. 2013 Sep 21;11(35):5798-808
pubmed: 23900343
J Med Chem. 1999 Nov 4;42(22):4614-20
pubmed: 10579823
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
pubmed: 11274893
J Nutr Sci. 2020 Jan 20;9:e2
pubmed: 32042410
Biomed Pharmacother. 2005 Aug;59(7):365-73
pubmed: 16081237
J Cheminform. 2014 Mar 11;6(Suppl 1):O25
pubmed: 24765124
Exp Mol Pathol. 2017 Apr;102(2):360-369
pubmed: 28315688
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1590-5
pubmed: 16439118
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7
pubmed: 15980490
J Mol Graph Model. 2002 Jan;20(4):305-9
pubmed: 11858639

Auteurs

Natalja Fjodorova (N)

National Institute of Chemistry, Ljubljana, Slovenia.

Marjana Novič (M)

National Institute of Chemistry, Ljubljana, Slovenia.

Katja Venko (K)

National Institute of Chemistry, Ljubljana, Slovenia.

Viktor Drgan (V)

National Institute of Chemistry, Ljubljana, Slovenia.

Bakhtiyor Rasulev (B)

North Dakota State University, Fargo, ND, USA.

Melek Türker Saçan (M)

Bogazici University, Institute of Environmental Sciences, Istanbul, Turkey.

Safiye Sağ Erdem (S)

Marmara University, Department of Chemistry, Istanbul, Turkey.

Gulcin Tugcu (G)

Yeditepe University, Faculty of Pharmacy, Istanbul, Turkey.

Alla P Toropova (AP)

Laboratory of Environmental Chemistry and Toxicology, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri, 2, Milano 20156, Italy.

Andrey A Toropov (AA)

Laboratory of Environmental Chemistry and Toxicology, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri, 2, Milano 20156, Italy.

Classifications MeSH